Skip to main content
SpringerLink
Log in

Vascular Cognitive Impairment

  • Chapter
  • First Online:
Book cover Mind and Brain

  • 829 Accesses

Abstract

Dementia represents a significant public health issue, as it is a leading cause of disability and the requirement of personal care assistance, particularly in the elderly. The second most common etiological factor contributing to dementia is a cerebrovascular disease, as it is the cause of vascular cognitive impairment and vascular dementia. We can recognize the full spectrum of cognition, from vascular mild cognitive impairment to vascular dementia. There are two forms of vascular cognitive impairment: post-stroke and non-stroke related. The diagnosis of probable vascular cognitive impairment requires confirmation of cognitive impairment, cerebrovascular disease, and a clear relationship between the two conditions. A combination of history, examination, and neuroimaging are fundamental for the assessment of the presence of cerebrovascular disease. The role of neuroimaging is particularly important in the diagnosis of vascular cognitive impairment, to confirm the presence, location, and severity of the cerebrovascular disease. Treatment of vascular cognitive impairment should be aimed at treating vascular risk factors and lifestyle modification.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bowler JV. Vascular cognitive impairment. J Neurol Neurosurg Psychiatry. 2005;76(Suppl 5):v35–44. Epub 2005/11/18.

    Article  Google Scholar 

  2. Yoshida D, Ninomiya T, Doi Y, Hata J, Fukuhara M, Ikeda F, et al. Prevalence and causes of functional disability in an elderly general population of Japanese: the Hisayama study. J Epidemiol. 2012;22(3):222–9. Epub 2012/02/22.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987;76(5):465–79. Epub 1987/11/01.

    Article  CAS  PubMed  Google Scholar 

  4. Patterson C, Gauthier S, Bergman H, Cohen C, Feightner JW, Feldman H, et al. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. Can J Neurol Sci. 2001;28 Suppl 1:S3–16. Epub 2001/03/10.

    Article  Google Scholar 

  5. Bowler JV. Modern concept of vascular cognitive impairment. Br Med Bull. 2007;83:291–305. Epub 2007/08/07.

    Article  CAS  PubMed  Google Scholar 

  6. Salihovic D, Smajlovic D, Mijajlovic M, Zoletic E, Ibrahimagic OC. Cognitive syndromes after the first stroke. Neurol Sci: Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2018;39(8):1445–51. Epub 2018/05/21.

    Article  PubMed  Google Scholar 

  7. Lee AY. Vascular dementia. Chonnam Med J. 2011;47(2):66–71. Epub 2011/11/24.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Cunningham EL, McGuinness B, Herron B, Passmore AP. Dementia. Ulst Med J. 2015;84(2):79–87. Epub 2015/07/15.

    Google Scholar 

  9. Petersen RC. Early diagnosis of Alzheimer’s disease: is MCI too late? Curr Alzheimer Res. 2009;6(4):324–30. Epub 2009/08/20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kalaria RN. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease. Acta Neuropathol. 2016;131(5):659–85. Epub 2016/04/12.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80(4):844–66. Epub 2013/11/26.

    Article  CAS  PubMed  Google Scholar 

  12. Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001;22(4):575–80. Epub 2001/07/11.

    Article  CAS  PubMed  Google Scholar 

  13. Casolla B, Leys D. Stroke and dementia. In: Brainin M, Heiss W-D, editors. Textbook of stroke medicine, 2nd ed. Cambridge University Press; 2014. p. 255–65.

    Google Scholar 

  14. Mijajlovic MD, Pavlovic A, Brainin M, Heiss WD, Quinn TJ, Ihle-Hansen HB, et al. Post-stroke dementia—a comprehensive review. BMC Med. 2017;15(1):11. Epub 2017/01/18.

    Google Scholar 

  15. Demarin V, Basic Kes V, Trkanjec Z, Budisic M, Bosnjak Pasic M, Crnac P, et al. Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial. Neuropsychiatr Dis Treat. 2017;13:483–90. Epub 2017/03/01.

    Google Scholar 

  16. Roman GC. Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci. 2002;203–204:7–10. Epub 2002/11/06.

    Article  PubMed  Google Scholar 

  17. Hachinski V, Einhaupl K, Ganten D, Alladi S, Brayne C, Stephan BCM, et al. Preventing dementia by preventing stroke: The Berlin Manifesto. Alzheimer’s Dement J Alzheimer’s Assoc. 2019;15(7):961–84. Epub 2019/07/23.

    Article  Google Scholar 

  18. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69(24):2197–204. Epub 2007/06/15.

    Article  PubMed  Google Scholar 

  19. Kalaria RN. The pathology and pathophysiology of vascular dementia. Neuropharmacology. 2018;134(Pt B):226–39. Epub 2017/12/24.

    Article  CAS  PubMed  Google Scholar 

  20. Niwa K, Porter VA, Kazama K, Cornfield D, Carlson GA, Iadecola C. A beta-peptides enhance vasoconstriction in cerebral circulation. Am J Physiol Heart Circ Physiol. 2001;281(6):H2417–24. Epub 2001/11/16.

    Google Scholar 

  21. Olsson B, Hertze J, Lautner R, Zetterberg H, Nagga K, Hoglund K, et al. Microglial markers are elevated in the prodromal phase of Alzheimer’s disease and vascular dementia. J Alzheimer’s Dis: JAD. 2013;33(1):45–53. Epub 2012/08/15.

    Article  CAS  Google Scholar 

  22. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010;120(3):287–96. Epub 2010/07/14.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Trapp BD, Stys PK. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 2009;8(3):280–91. Epub 2009/02/24.

    Article  CAS  PubMed  Google Scholar 

  24. Zhang F, Eckman C, Younkin S, Hsiao KK, Iadecola C. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. J Neurosci: Off J Soc Neurosci. 1997;17(20):7655–61. Epub 1997/10/07.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Koike MA, Green KN, Blurton-Jones M, Laferla FM. Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am J Pathol. 2010;177(1):300–10. Epub 2010/05/18.

    Google Scholar 

  26. Gorelick PB, Nyenhuis D. Understanding and treating vascular cognitive impairment. Continuum (Minneap Minn). 2013;19(2 Dementia):425–37. Epub 2013/04/06.

    PubMed  Google Scholar 

  27. Farooq MU, Gorelick PB. Vascular cognitive impairment. Current atherosclerosis reports. 2013;15(6):330. Epub 2013/04/25.

    Google Scholar 

  28. Smith E. Vascular cognitive impairment. Continuum (Minneap Minn). 2016;22(2 Dementia):490–509. Epub 2016/04/05.

    PubMed  Google Scholar 

  29. Leys D, Erkinjuntti T, Desmond DW, Schmidt R, Englund E, Pasquier F, et al. Vascular dementia: the role of cerebral infarcts. Alzheimer Dis Assoc Disord. 1999;13(Suppl 3):S38–48. Epub 1999/12/28.

    Article  Google Scholar 

  30. McKay E, Counts SE. Multi-infarct dementia: a historical perspective. Dement Geriatr Cogn Disord Extra. 2017;7(1):160–71. Epub 2017/06/20.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Sachdev P, Kalaria R, O’Brien J, Skoog I, Alladi S, Black SE, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28(3):206–18. Epub 2014/03/19.

    Article  CAS  Google Scholar 

  32. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250–60. Epub 1993/02/01.

    Article  CAS  PubMed  Google Scholar 

  33. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(9):2672–713. Epub 2011/07/23.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Association AP. Diagnostic and statistical manual of mental disorders, 5th ed. Washington, DC; 2013.

    Google Scholar 

  35. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology. 1992;42(3 Pt 1):473–80. Epub 1992/03/01.

    Article  CAS  PubMed  Google Scholar 

  36. Organization WH. The ICD-10classification of mental and behavioural disorders. Switzerland: Diagnostic criteria for research Geneva; 1993.

    Google Scholar 

  37. Longstreth WT Jr. Brain vascular disease overt and covert. Stroke. 2005;36(10):2062–3. Epub 2005/09/30.

    Article  PubMed  Google Scholar 

  38. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of psychiatric research. 1975;12(3):189–98. Epub 1975/11/01.

    Article  CAS  PubMed  Google Scholar 

  39. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9. Epub 2005/04/09.

    Article  PubMed  Google Scholar 

  40. Aprahamian I, Martinelli JE, Neri AL, Yassuda MS. The clock drawing test: a review of its accuracy in screening for dementia. Dement Neuropsycholo. 2009;3(2):74–81. Epub 2009/04/01.

    Article  Google Scholar 

  41. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet. 1974;2(7874):207–10. Epub 1974/07/27.

    Article  Google Scholar 

  42. Pendlebury ST, Cuthbertson FC, Welch SJ, Mehta Z, Rothwell PM. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke. 2010;41(6):1290–3. Epub 2010/04/10.

    Article  PubMed  Google Scholar 

  43. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38. Epub 2013/07/23.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Smith EE, Schneider JA, Wardlaw JM, Greenberg SM. Cerebral microinfarcts: the invisible lesions. Lancet Neurol. 2012;11(3):272–82. Epub 2012/02/22.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Haridimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry. 2012;83(2):124–37. Epub 2011/11/08.

    Google Scholar 

  46. Federico A, Di Donato I, Bianchi S, Di Palma C, Taglia I, Dotti MT. Hereditary cerebral small vessel diseases: a review. J Neurol Sci. 2012;322(1–2):25–30. Epub 2012/08/08.

    Article  PubMed  Google Scholar 

  47. Black SE. Vascular cognitive impairment: epidemiology, subtypes, diagnosis and management. J R Coll Physicians Edinb. 2011;41(1):49–56. Epub 2011/03/03.

    Article  CAS  PubMed  Google Scholar 

  48. Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120(3):472–95. Epub 2017/02/06.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701. Epub 2010/07/09.

    Article  PubMed  Google Scholar 

  50. Dufouil C, Chalmers J, Coskun O, Besancon V, Bousser MG, Guillon P, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril protection against recurrent stroke study) magnetic resonance imaging substudy. Circulation. 2005;112(11):1644–50. Epub 2005/09/08.

    Article  PubMed  Google Scholar 

  51. Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J, Antikainen R, et al. The Finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER): study design and progress. Alzheimer’s Dement J Alzheimer’s Assoc. 2013;9(6):657–65. Epub 2013/01/22.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Sveti Duh University Hospital, Zagreb, Croatia

    Petra Črnac Žuna & Hrvoje Budinčević

  2. Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia

    Hrvoje Budinčević

  3. Department of Radiology, Sveti Duh University Hospital, Zagreb, Croatia

    Tena Sučić Radovanović

  4. Clinical Center of Serbia and School of Medicine University of Belgrade, Neurology Clinic, Belgrade, Serbia

    Milija Mijajlović

  5. Brain Division, Shaare Zedek Medical Center, Jerusalem, Israel

    Natan Bornstein

Authors
  1. Petra Črnac Žuna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hrvoje Budinčević
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tena Sučić Radovanović
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Milija Mijajlović
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Natan Bornstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hrvoje Budinčević .

Editor information

Editors and Affiliations

  1. International Institute for Brain Health, Zagreb, Croatia

    Vida Demarin

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Črnac Žuna, P., Budinčević, H., Sučić Radovanović, T., Mijajlović, M., Bornstein, N. (2020). Vascular Cognitive Impairment. In: Demarin, V. (eds) Mind and Brain. Springer, Cham. https://doi.org/10.1007/978-3-030-38606-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-38606-1_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-38605-4

  • Online ISBN: 978-3-030-38606-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation